SYNTHESE VON MDMA ODER IHREN OPTISCH AKTIVEN (R)- ODER (S)-MDMA ISOMEREN
European patent · EP4396305 · In force
Register entry
- Publication number
- EP4396305
- Application number
- EP22865560
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Sep 1, 2022
- Published
- Jul 10, 2024
- Granted
- May 6, 2026
- Protection ends at the latest
- Aug 31, 2042
- Next annual fee due
- Sep 30, 2027
- IPC classes
- C07D 317/58 (2006.01)
- Priority
- US 202163239853 P 01.09.2021
- PCT application
- PCT/US2022/042353 01.09.2022
- PCT publication
- WO2023/034510 09.03.2023
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 1, 2026
Next annual fee due on
- Next annual fee due on
- 30.09.2026 → 30.09.2027
Published in Swissreg on 01.10.2026
- Aug 12, 2026
Owner
- Owner
- EmpathBio, Inc., Industrious NYC, 250 West 34th St, New York, NY 10119, USA → EmpathBio, Inc., c/o Industrious NYC, 250 West 34th St, New York, NY 10119, USA
Published in Swissreg on 12.08.2026
- Jul 22, 2026
Change
Published in Swissreg on 22.07.2026
- Jul 15, 2026
Owner
- Owner
- EmpathBio, Inc., 1477 Paseo De Las Flores, Encinitas, CA 92024, USA → EmpathBio, Inc., Industrious NYC, 250 West 34th St, New York, NY 10119, USA
Published in Swissreg on 15.07.2026
- May 6, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 06.05.2026
Parties
Inventor
MORRA, Nicholas
Encinitas, California 92024, US
FAWAZ, Majed
Encinitas, California 92024, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.